A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence
| Status: | Completed |
|---|---|
| Conditions: | HIV / AIDS |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 19 - Any |
| Updated: | 4/29/2018 |
| Start Date: | September 2008 |
| End Date: | October 2009 |
This study will enroll completers of a prior 24 week MEMS cap study of Kaletra adherence,
conducted in 2005 - 2006, and repeat the MEMS monitoring for an additional 24 weeks in
2008/2009 on the current antiretroviral anchor drug. The goals of the study are to correlate
long-term adherence with virologic outcome, and to explore the stability of MEMS cap
adherence measurements over time.
conducted in 2005 - 2006, and repeat the MEMS monitoring for an additional 24 weeks in
2008/2009 on the current antiretroviral anchor drug. The goals of the study are to correlate
long-term adherence with virologic outcome, and to explore the stability of MEMS cap
adherence measurements over time.
Inclusion Criteria:
- Participation in the prior Kaletra MEMS cap study
Exclusion Criteria:
- Not receiving antiretroviral therapy, refusal to provide informed consent
We found this trial at
1
site
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
Click here to add this to my saved trials
